Current Issue
March 2026 — Volume 1, Issue 1
Table of Contents
-
-
- Clinical Research FDA Approves Lilly's Orforglipron; Trump Pharma Tariffs LoomKeala Nakamura April 4, 2026
-
- Public Health Pharma Delays European Drug Launches Over US Pricing PolicyKeala Nakamura April 2, 2026
-
-
-
- Clinical Research Sarepta Therapeutics Shares Surge on Rare Disease Drug DataKeala Nakamura March 30, 2026
- Public Health Parenting Challenges in Primary Care: The GP Workforce GapMichael O'Connor March 30, 2026
-
- Medical Technology Radiologists Can't Spot AI Deepfake X-Rays, Study FindsPriya Patel March 29, 2026
- Clinical Research Electronic Marking Systems to Prevent Medical Exam ErrorsMichael O'Connor March 29, 2026
- Infectious Disease Pfizer Lyme Vaccine Shows 70% Efficacy But Misses Statistical GoalMichael O'Connor March 28, 2026
-
- Clinical Research FDA Approves Kresladi Gene Therapy for Rare LAD-1 DiseaseRobert Kim March 28, 2026
- Medical Technology Doctronic Raises $40M Series B to Expand AI Clinical CarePriya Patel March 27, 2026
-
- Clinical Research Novo Nordisk Faces Investor Pressure at 2026 Annual MeetingKeala Nakamura March 27, 2026
- Public Health 24 States Sue EPA Over Greenhouse Gas Endangerment RollbackMichael O'Connor March 26, 2026
Editor's Picks
- FDA Delays Force Kezar Life Sciences to Shut Down Keala Nakamura
- FDA Approves Lilly's Orforglipron; Trump Pharma Tariffs Loom Keala Nakamura
- FDA Eyes Reversal on Peptide Compounding Ban James Liu
- BMJ Retracts PREVENT-TAHA8 Stem Cell Heart Failure Trial James Liu
Most Cited
- FDA Delays Force Kezar Life Sciences to Shut Down 20 citations
- Trump's 100% Drug Tariffs: What You Need to Know 16 citations
- FDA Approves Lilly's Orforglipron; Trump Pharma Tariffs Loom 24 citations
- FDA Eyes Reversal on Peptide Compounding Ban 12 citations
- Pharma Delays European Drug Launches Over US Pricing Policy 16 citations
For Authors
Hawaii Medical Journal welcomes research submissions, case reports, and correspondence.
Submit a ManuscriptArchives
Browse past issues